AHSN Impact Report 2022 | Page 54

Supporting the MedTech Funding Mandate

The NHS Long Term Plan committed to accelerate the uptake of selected innovative medical devices and digital products by developing the MedTech Funding Mandate policy . As an AHSN , it is our role to help the adoption and spread of these innovations , and our Programme Lead , Stephanie Potts , explains the work we have been doing to help promote these products to our NHS partners .
We have established strong working relationships with the companies selected for this year ’ s MedTech Funding Mandate and this has helped to facilitate the spread and uptake of these innovations in NHS organisations across our region .
This year , the four products have been :
1 . Placental growth factor ( PlGF ) -based testing – a blood test to rule out preeclampsia in pregnant women .
2 . SecurAcath – for securing percutaneous catheters .
Stephanie Potts , Programme Lead
54 Transforming Lives Through Innovation